Acknowledgements
We thank all the patients who participated in the MedBridge trial, and
Christine Jonsson and Marika Callmar for their help with data analysis.
We would like to acknowledge the other MedBridge research group members:
Maria Bertilsson, Johanna Carlsson and Åke Tenerz. This study was part
of the MedBridge project, which has received governmental research
grants RFR-555601, RFR-641791, and RFR-735911 from the Uppsala-Örebro
Regional Research Council, grants LUL-527721, LUL-614061, LUL-716201,
and LUL-821261 from Region Uppsala, grants CFUG-658451 and CFUG-698771
from Region Gävleborg, and grants LTV-675921, LTV-712341, LTV-736641,
and LTV-840112 from Region Västmanland, funding from the Swedish
Pharmacists Association (Sveriges Farmaceuter), the Thuréus Fund for
Geriatric Research (Thuréus stiftelse för främjande av geriatrisk
forskning) and the Geriatric Fund (Geriatriska fonden) and grants
FA2017:38 and FA2018:43 from the Swedish Heart and Lung Association
(Riksförbundet HjärtLung).